NIKKEI 225
39,658.15 +485.00 (+1.24%) HANG SENG
18,069.19 -3.71 (-0.02%) CRUDE OIL
81.00 +0.17 (+0.21%) GOLD FUTURES
2,325.40 -5.40 (-0.23%) DOW
39,112.16 -299.05 (-0.76%) Bitcoin GBP
49,064.38 +1,319.59 (+2.76%)
TXG Dec 2024 17.500 call
| Previous close | 7.50 |
| Open | 7.50 |
| Bid | 3.60 |
| Ask | 5.60 |
| Strike | 17.50 |
| Expiry date | 2024-12-20 |
| Day's range | 7.50 - 7.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 5 |
Insider MonkeyDoes 10x Genomics (TXG) Have a Strong Growth Opportunity Ahead?
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The Small Company Fund returned 0.48%, significantly underperforming the Russell 2000 Growth index’s 7.58% return. Following the release of the inflation report in February, the […]
PR Newswire10x Genomics Begins Commercial Shipments of Xenium Prime 5K Pan-Tissue and Pathways Panel
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that it has started shipping its new Xenium Prime 5K Pan-Tissue and Pathways panel. The new panel features an enhanced chemistry to increase plex by an order of magnitude while delivering excellent per-gene sensitivity, improved specificity and spatial fidelity, integrated multimodal cell segmentation and industry-leading speed and throughput.
Simply Wall St.We Think Some Shareholders May Hesitate To Increase 10x Genomics, Inc.'s (NASDAQ:TXG) CEO Compensation
Key Insights 10x Genomics to hold its Annual General Meeting on 11th of June Total pay for CEO Serge Saxonov includes...
